what is better for weight loss semaglutide or tirzepatide Zepbound vs Wegovy: vs Weight loss isn't one-size-fits-all. Both

Wester continued, Given that the metabolic syndrome is a major driver of liver-related outcomes both in patients with MASLD and other chronic liver diseases such as alcohol-related liver disease or viral hepatitis C, there could be a similar effect of GLP1 agonists in patients with chronic liver diseases of any etiology with concomitant metabolic traits, such as type 2 diabetes. Using data from the Decoding the Epidemiology of LIVER disease Swedish cohort, researchers aimed to determine the long-term risk for major adverse liver outcomes (MALO) among patients with chronic liver disease and type 2 diabetes who either initiated (n = 1,026) or did not initiate (n = 15,633) GLP1 agonists

Take Care of Your Gut Health The gut plays an important role in digestion, and maintaining a healthy gut can help manage diarrhea

Better signal.

In: Bonora, E., DeFronzo, R